A lack of HIF-1 activity results in reduced angiogenesis and slower tumor growth rates 1,5, whereas increased HIF-1 activity promotes resistance of cancer cells to treatment by chemo- and radiotherapy 6 and is associated with poor prognosis in many cancer types 7,8. Here, HIF1A is linked to neoplasm.